Serum and urinary levels of MIF, CD74, DDT and CXCR4 among patients with type 1 diabetes mellitus, type 2 diabetes and healthy individuals: Implications for further research

The increased serum MIF levels and urinary CD74 levels among patients with T1DM may be attributed to the autoimmune milieu, which characterises patients with T1DM, when compared to patients with T2DM. These two findings merit further attention as they could pave the way for further research regarding the potential beneficial effects of inhibitors of MIF among patients with T1DM, especially in the early stages of T1DM. Finally, the role of inhibitors of MIF could be further explored in the context of obesity among patients with T2DM.

Authors

Institutions

Publication Details

Journal
Metabolism Open
Published
2024-09-15
DOI
https://doi.org/10.1016/j.metop.2024.100320
Citations
10
Primary Topic
Macrophage Migration Inhibitory Factor
Type
article
Field-Weighted Citation Impact
2.40
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Serum and urinary levels of MIF, CD74, DDT and CXCR4 among patients with type 1 diabetes mellitus, type 2 diabetes and healthy individuals: Implications for further research

Fotis Panagopoulos, Μaria Dalamaga, Paolo Fagone, Dimitris Kounatidis et al.
10 citations
Metabolism Open
Macrophage Migration Inhibitory Factor
2.40
article

Serum and urinary levels of MIF, CD74, DDT and CXCR4 among patients with type 1 diabetes mellitus, type 2 diabetes and healthy individuals: Implications for further research

Fotis Panagopoulos, Μaria Dalamaga, Paolo Fagone, Dimitris Kounatidis, Katia Mangano, Natalia G. Vallianou, Aristidis Diamantopoulos, Theodora Stratigou, Ferdinando Nicoletti
article en
10 citations

Abstract

The increased serum MIF levels and urinary CD74 levels among patients with T1DM may be attributed to the autoimmune milieu, which characterises patients with T1DM, when compared to patients with T2DM. These two findings merit further attention as they could pave the way for further research regarding the potential beneficial effects of inhibitors of MIF among patients with T1DM, especially in the early stages of T1DM. Finally, the role of inhibitors of MIF could be further explored in the context of obesity among patients with T2DM.

Metabolism OpenVol. 24
National and Kapodistrian University of Athens (GR), University of Catania (IT), Evangelismos Hospital (GR)
Zero hunger
Openalex Percentile: Top 11%
Macrophage Migration Inhibitory Factor
2.40
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Serum and urinary levels of MIF, CD74, DDT and CXCR4 among patients with type 1 diabetes mellitus, type 2 diabetes and healthy individuals: Implications for further research — Fotis Panagopoulos, Μaria Dalamaga, et al. · Metabolism Open (2024) | TGRS Research Map | TGRS